- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA Clears Delphinus’s Breast Ultrasound Tomography System
Delphinus Medical Technologies Inc., a Michigan-based ultrasound company, has received FDA 510(k) clearance for its whole breast ultrasound tomography system for diagnostic breast imaging.
The SoftVue system uses ring transducer technology to transmit and receive ultrasound signals. Traditional hand-held ultrasound and automated breast ultrasound systems obtain reflected echoes returning in the direction of the linear transducer, where this system captures reflection echoes from all directions around the breast and gathers transmitted signals coming through the breast, according to the company. There is currently no other ultrasound system available that does that, the company said.
The breast is suspended in warm water, and the exams are one to two minutes per breast, the company said. SoftVue provides a complete map of the whole breast, and the exam is more consistent and uniform than traditional ultrasound, according to the company.
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.
